INT33848

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.36
First Reported 1986
Last Reported 2006
Negated 1
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 0.88
Pain Relevance 2.04

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (C6) extracellular region (C6) molecular_function (C6)
C6 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Dopamine 6 100.00 Very High Very High Very High
agonist 20 99.68 Very High Very High Very High
Bioavailability 1 98.20 Very High Very High Very High
local anesthetic 12 96.48 Very High Very High Very High
Morphine 2 70.56 Quite High
Pain 4 5.00 Very Low Very Low Very Low
Facet joint 3 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Spinal cord 1 5.00 Very Low Very Low Very Low
Sciatica 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hyperplasia 100 99.90 Very High Very High Very High
Disease 31 95.92 Very High Very High Very High
Osteoarthritis 53 88.76 High High
Osteophyte 4 28.60 Quite Low
Hypertrophy 2 18.00 Low Low
Sclerosis 3 15.96 Low Low
Stress 5 5.00 Very Low Very Low Very Low
Arthropathy 5 5.00 Very Low Very Low Very Low
Injury 2 5.00 Very Low Very Low Very Low
INFLAMMATION 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Esters synthesized link dopamine and L-dopa, by a succinyl linker, to C-3 position of glucose (I and II) and to C-6 of galactose (II and IV).
C-6 Binding (link) of associated with dopamine
1) Confidence 0.36 Published 2003 Journal J Drug Target Section Abstract Doc Link 12852438 Disease Relevance 0 Pain Relevance 0.33
Our initial assumption of achieving approximately the previously reported 46% prevalence of CPH was true for C5 and C6 but the actual prevalence at C3 and C4 was lower.
C6 Binding (true) of associated with hyperplasia
2) Confidence 0.03 Published 2006 Journal Chiropr Osteopat Section Body Doc Link PMC1592100 Disease Relevance 0.88 Pain Relevance 0
These findings show that C6SLMel binds to the allosterically coupled noncompetitive inhibitor site which is regulated by agonist binding.
C6SLMel Binding (binds) of associated with agonist
3) Confidence 0.01 Published 1986 Journal Mol. Pharmacol. Section Abstract Doc Link 3018481 Disease Relevance 0 Pain Relevance 0.45
In addition, C6SLMel preferentially associates with the desensitized receptor state known to exhibit high affinities for agonists and local anesthetics.
C6SLMel Binding (associates) of associated with agonist and local anesthetic
4) Confidence 0.01 Published 1986 Journal Mol. Pharmacol. Section Abstract Doc Link 3018481 Disease Relevance 0 Pain Relevance 0.47
At concentrations lower than 1 X 10(-5) M, C6SLMel does not bind to the agonist site but enhances [3H]acetylcholine binding.
C6SLMel Neg (not) Binding (bind) of associated with agonist
5) Confidence 0.01 Published 1986 Journal Mol. Pharmacol. Section Abstract Doc Link 3018481 Disease Relevance 0 Pain Relevance 0.44
Furthermore, in the presence of carbamylcholine, back-titration of bound C6SLMel with phencyclidine decreases the highly immobilized component at concentrations consistent with the KD for phencyclidine.
C6SLMel Binding (bound) of
6) Confidence 0.01 Published 1986 Journal Mol. Pharmacol. Section Abstract Doc Link 3018481 Disease Relevance 0 Pain Relevance 0.35

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox